Hasson H - Search Results

1

The albumin-bilirubin grade uncovers the prognostic relationship between hepatic reserve and immune dysfunction in HIV-associated hepatocellular carcinoma.

Pinato DJ, Sharma R, Citti C, Platt H, Ventura-Cots M, Allara E, Chen TY, Dalla Pria A, Jain M, Mínguez B, Kikuchi L, Kaufman West E, Merli M, Kaplan DE, Hasson H, Marks K, Nelson M, Núñez M, Aytaman A, Bower M, Bräu N; Liver Cancer in HIV Study Group. Pinato DJ, et al. Among authors: hasson h. Aliment Pharmacol Ther. 2018 Jan;47(1):95-103. doi: 10.1111/apt.14356. Epub 2017 Oct 16. Aliment Pharmacol Ther. 2018. PMID: 29034998 Free article.

2

HAART simplification with lopinavir/ritonavir monotherapy in HIV/HCV co-infected patients starting anti-HCV treatment: a randomised pilot study (KaMon study).

Hasson H, Galli L, Gallotta G, Neri V, Blanc P, D'Annunzio M, Morsica G, Sollima S, Merli M, Lazzarin A, Uberti-Foppa C. Hasson H, et al. New Microbiol. 2012 Oct;35(4):469-74. Epub 2012 Oct 1. New Microbiol. 2012. PMID: 23109014 Free article. Clinical Trial.

3

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.

Hasson H, Merli M, Galli L, Gallotta G, Carbone A, Messina E, Bagaglio S, Morsica G, Salpietro S, Castagna A, Lazzarin A, Uberti-Foppa C. Hasson H, et al. Liver Int. 2013 Aug;33(7):1113-20. doi: 10.1111/liv.12159. Epub 2013 Mar 28. Liver Int. 2013. PMID: 23534616

4

Sustained virological response after ten days of triple anti-hepatitis C virus (HCV) therapy with telaprevir plus pegylated interferon and ribavirin in an HIV/HCV co-infected cirrhotic woman.

Hasson H, Messina E, Merli M, Della Torre L, Morsica G, Bagaglio S, Lazzarin A, Uberti-Foppa C. Hasson H, et al. Int J Infect Dis. 2014 Dec;29:100-2. doi: 10.1016/j.ijid.2014.08.011. Epub 2014 Oct 24. Int J Infect Dis. 2014. PMID: 25449243 Free article.

5

Distribution of natural resistance to NS3 protease inhibitors in hepatitis C genotype 1a separated into clades 1 and 2 and in genotype 1b of HIV-infected patients.

Bagaglio S, Uberti-Foppa C, Messina E, Merli M, Hasson H, Andolina A, Galli A, Lazzarin A, Morsica G. Bagaglio S, et al. Among authors: hasson h. Clin Microbiol Infect. 2016 Apr;22(4):386.e1-386.e3. doi: 10.1016/j.cmi.2015.12.007. Epub 2015 Dec 17. Clin Microbiol Infect. 2016. PMID: 26706617 Free article.

6

Impact of PNPLA3 variants on liver histology of 168 patients with HIV infection and chronic hepatitis C.

Sagnelli C, Merli M, Uberti-Foppa C, Hasson H, Cirillo G, Grandone A, Salpietro S, Minichini C, Del Giudice EM, Lazzarin A, Sagnelli E, Coppola N. Sagnelli C, et al. Among authors: hasson h. Clin Microbiol Infect. 2016 Apr;22(4):372-378. doi: 10.1016/j.cmi.2015.11.025. Epub 2016 Jan 20. Clin Microbiol Infect. 2016. PMID: 26806136 Free article.

7

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir-based therapy.

Campos-Varela I, Moreno A, Morbey A, Guaraldi G, Hasson H, Bhamidimarri KR, Castells L, Grewal P, Baños I, Bellot P, Brainard DM, McHutchison JG, Terrault NA. Campos-Varela I, et al. Among authors: hasson h. Aliment Pharmacol Ther. 2016 Jun;43(12):1319-29. doi: 10.1111/apt.13629. Epub 2016 Apr 21. Aliment Pharmacol Ther. 2016. PMID: 27098374 Free article.

8

Diagnostic accuracy of APRI, FIB-4 and Forns for the detection of liver cirrhosis in HIV/HCV-coinfected patients.

Merli M, Galli L, Castagna A, Salpietro S, Gianotti N, Messina E, Poli A, Morsica G, Bagaglio S, Cernuschi M, Bigoloni A, Uberti-Foppa C, Lazzarin A, Hasson H. Merli M, et al. Among authors: hasson h. New Microbiol. 2016 Apr;39(2):110-3. New Microbiol. 2016. PMID: 27196548 Free article.

9

Pharmacokinetics of dolutegravir and rilpivirine in combination with simeprevir and sofosbuvir in HIV/hepatitis C virus-coinfected patients with liver cirrhosis.

Merli M, Galli L, Marinaro L, Ariaudo A, Messina E, Uberti-Foppa C, Castagna A, D'Avolio A, Lazzarin A, Bonora S, Hasson H. Merli M, et al. Among authors: hasson h. J Antimicrob Chemother. 2017 Mar 1;72(3):812-815. doi: 10.1093/jac/dkw492. J Antimicrob Chemother. 2017. PMID: 27999010

10

Occurrence of hepatocellular carcinoma in HIV/HCV co-infected patients treated with direct-acting antivirals.

Hasson H, Merli M, Messina E, Bhoori S, Salpietro S, Morsica G, Regalia E, Bagaglio S, Lazzarin A, Uberti-Foppa C, Mazzaferro V. Hasson H, et al. J Hepatol. 2017 Aug;67(2):415-417. doi: 10.1016/j.jhep.2017.03.032. Epub 2017 Apr 12. J Hepatol. 2017. PMID: 28411040 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

270 results

Search Page